INTRODUCTION
============

Cell shape changes are central to the formation of tissue structure. One of the earliest and most highly conserved vertebrate brain structures that forms during development is the tissue fold at the midbrain--hindbrain boundary (MHB; [@B26]; [@B23]; [@B15]). Using the zebrafish MHB as a model to understand brain morphogenesis, we characterized the basic cell shape changes that are required to fold the neuroepithelium in this region ([@B12], [@B13]). Zebrafish MHB formation is initiated at the 18-somite stage (ss) after the neural tube has formed. Cells at the point of deepest constriction at the MHB---the MHB constriction (MHBC)---shorten and narrow by 24 ss ([@B13]). By primordium-6 stage, cells at the MHBC constrict basally and expand apically, leading to an acute tissue angle and clear delineation of the midbrain from the hindbrain ([@B12]). The initial cell shape changes are differentially regulated by myosin motor proteins. Apical-basal cell length is specifically regulated by nonmuscle myosin IIA (NMIIA), and anterior-posterior cell width is specifically regulated by nonmuscle myosin IIB (NMIIB; [@B13]). However, the molecular pathways that activate NMII proteins to differentially mediate these cell shape changes remain unknown.

NMII activity can be regulated by several different kinase cascades via phosphorylation of myosin regulatory light chain (MRLC). Calcium (Ca^2+^) signaling plays a critical role in mediating phosphorylation of MRLC via myosin light chain kinase (MLCK; [@B3]; [@B29]; [@B34]) and is critical for many embryonic developmental processes ([@B35]; [@B28]). However, the specific role for Ca^2+^ signaling in brain morphogenesis is unknown. We hypothesized that Ca^2+^ functions as a morphogenetic signal to mediate cell shape changes at the MHB. We demonstrate that intracellular Ca^2+^ signals specifically determine cell length at the MHBC and that Ca^2+^ regulation of cell shape depends on NMII activity. We further demonstrate that proper regulation of MHBC cell shape requires *calmodulin 1a* (*calm1a*) and MLCK. Our data show for the first time that modulation of NMII function by Ca^2+^ is critical for regulation of MHBC cell length to determine embryonic brain shape during development.

RESULTS AND DISCUSSION
======================

Ca^2+^ mediates cell length at the MHBC during brain development
----------------------------------------------------------------

In zebrafish, Ca^2+^ signals precede morphological patterning in the brain ([@B36]), and apical-basal cell thinning in the enveloping layer cells depends on Ca^2+^ transients ([@B38]). Ca^2+^ flashes have also been shown to drive apical constriction during neural tube closure ([@B7]). Therefore we investigated intracellular Ca^2+^ flashes in the MHB during morphogenesis. We used four-dimensional time-lapse imaging of GCaMP6s--green fluorescent protein (GFP) mRNA--injected embryos to determine whether there were Ca^2+^ flashes in MHB cells at the time of initial MHB formation. We found single-cell Ca^2+^ transients to be enriched in the MHB region compared with surrounding regions at 18 ss, during the initiation of MHB morphogenesis ([Figure 1, A and B](#F1){ref-type="fig"}, and Supplemental Movie S1). We also found that apical-basal cell length decreased immediately after a Ca^2+^ transient specifically in the MHB region ([Figure 1, C--F](#F1){ref-type="fig"}). Therefore we hypothesized that Ca^2+^ signals may initiate MHB morphogenesis and that cells in this region are poised to respond to Ca^2+^ transients.

![Calcium transients are enriched in the MHB at 18 ss and precede decreases in cell length. (A) Representative wild-type 18 ss time-lapse images of intracellular Ca^2+^ transients (panels from Supplemental Movie S1). Asterisks indicate mitotic cells, and arrows indicate Ca^2+^ transients analyzed. (B) Quantification of Ca^2+^ transients at 18, 20, and 24 ss. (C--E) Representative wild-type images at 18 ss analyzed for cell length changes after Ca^2+^ transients. (F) Quantification indicating the amount of decrease in cell length immediately after Ca^2+^ transients. For statistical analysis, one-way ANOVA with Tukey's HSD post hoc test was conducted for Ca^2+^ transient frequency. \**p* \< 0.05, mean ± SEM. Embryos analyzed: 18 ss, *n* = 11; 20 ss, *n* = 10; 24 ss, *n* = 8. Mann--Whitney *U* test was performed for analysis of cell length decrease after Ca^2+^ transients. \*\*\**p* \< 0.001, mean ± SEM. Embryos analyzed, *n =* 10; MHB region cells, 17; outside MHB cells, 6. Arrowheads indicate the MHBC. Scale bars, 25 μm.](875fig1){#F1}

To investigate further the role of Ca^2+^ signals in regulating zebrafish MHB morphogenesis, we used pharmacological inhibitors to manipulate intracellular Ca^2+^ levels. We used 2-aminoethoxydiphenyl-borate (2-APB) to decrease intracellular Ca^2+^ levels ([@B4]; [@B1]) and thapsigargin (Thaps) to increase intracellular Ca^2+^ levels ([@B21]; [@B38]). Wild-type embryos were treated at 18 ss with dimethyl sulfoxide (DMSO), 2-APB, or Thaps. We analyzed cell shapes at 24 ss, after the initial morphogenetic events had occurred ([Figure 2, A--C](#F2){ref-type="fig"}′). We found that embryos with decreased intracellular Ca^2+^ (2-APB treated) had significantly longer cells at the MHBC, whereas embryos with increased intracellular Ca^2+^ (Thaps treated) had significantly shorter cells at the MHBC ([Figure 2D](#F2){ref-type="fig"}). Efficacy of 2-APB and Thaps was determined using the genetically encoded calcium indicator GCaMP6s-GFP (Supplemental Figure S2, A--D). Apoptosis and cell adhesion within the neuroepithelium, which are known to depend on intracellular Ca^2+^ homeostasis ([@B25]; [@B22]), were not affected by these treatments at the doses used (Supplemental Figure S2, E--K).

![Calcium regulates cell length at the MHBC. (A--C′) Confocal images of embryos injected with mGFP and treated at 18 ss with (A, A′) DMSO, (B, B′) 100 μM 2-APB, or (C, C′) 2 μM Thaps. Embryos were washed, incubated, and live imaged at 24 ss. (A′--C′) Magnifications of A--C. Arrowheads indicate the MHBC. Asterisks in A--C indicate cell outlined in A′--C′. (D, E) Cell length quantification at the MHBC and 40 μm outside the MHBC. For statistical analysis, one-way ANOVA with Tukey's HSD post hoc test was done. \*\*\**p* \< 0.001 compared with DMSO, mean ± SEM. For each measurement, DMSO (*n* = 29; 58 cells), 2-APB (*n* = 16; 32 cells), and Thaps (*n* = 14; 28 cells). Scale bars, 25 μm.](875fig2){#F2}

Quantification of Ca^2+^ effects on tissue shape showed that the MHBC angle was abnormal, as expected with changes in MHBC cell length, whereas MHB cell width was only slightly affected with Thaps treatment (Supplemental Figure S3, A and B). However, cells 40 μm posterior to the MHBC were not significantly different from controls after either treatment ([Figure 2E](#F2){ref-type="fig"}), indicating a region-specific effect on cell shape with Ca^2+^ manipulation. Ca^2+^ has been previously reported to regulate cell shape in other cell types. Thaps treatment causes cell retraction, gap formation, and actin rearrangement in cultured endothelial cells ([@B24]), and in cardiac myocytes, Ca^2+^ regulates cellular contraction, causing shortening of cells in vitro ([@B5]).

Calcium signals to nonmuscle myosin II to mediate cell shape at the MHB
-----------------------------------------------------------------------

On the basis of our previous work demonstrating that NMII proteins are critical mediators of cell shape at the MHB ([@B13]) and the known role for Ca^2+^ in regulation of NMII activity ([@B29]), we hypothesized that Ca^2+^ may mediate its effects on MHB cell shape via downstream activation of NMII. To test this hypothesis, we first determined whether increasing Ca^2+^ in the MHB would modulate phosphorylation of MRLC (pMRLC), an indicator of NMII activity ([@B34]). We treated wild-type embryos with DMSO or Thaps and microdissected MHB tissue for Western analysis of pMRLC. MHB dissections were confirmed to be specific using reverse transcription-PCR (RT-PCR) with tissue-specific markers (Supplemental Figure S4, A--D). Western analysis of MHB protein showed that pMRLC levels increased approximately twofold after Thaps treatment ([Figure 3, A and B](#F3){ref-type="fig"}), suggesting that increased intracellular Ca^2+^ leads to increased NMII activity. We were unable to detect a change in pMRLC with 2-APB treatment. This is consistent with the observed difference in the magnitude of effects on Ca^2+^ between 2-APB and Thaps. Specifically, 2-APB decreases Ca^2+^ by half, whereas Thaps increases Ca^2+^ by fivefold (Supplemental Figure S2, A--D).

![Calcium signals to NMII at the MHB to modulate MHBC cell length. (A) Representa­tive Western blot for pMRLC in MHB-specific tissue dissected after DMSO or 2 μM Thaps treatment. (B) pMRLC Western quantification using α-tubulin as a control (*n* = 4). (C) Hypothesized role of Ca^2+^ and NMII interactions. IF, increase in Ca^2+^ leads to increased pMRLC to activate NMII and causes shorter cells at the MHBC; AND, Bleb inhibits NMII function; THEN, Thaps treatment to increase Ca^2+^ leading to shorter cells can be rescued with NMII inhibition by Bleb. (D--G′) Confocal images of mGFP-injected embryos treated with (D, D′) DMSO/DMSO, (E, E′) Thaps/DMSO, (F, F′) DMSO/Bleb, or (G, G′) Thaps/Bleb. (D′--G′) Magnifications of D--G. Arrowheads indicate the MHBC. Asterisks in D--G indicate cell outlined in D′--G′. (H, I) Cell length quantification at the MHBC and 40 μm outside the MHBC. For statistical analysis, one-way ANOVA with Tukey's HSD post hoc test was done. \*\*\**p* \< 0.001 compared with DMSO/DMSO; mean ± SEM. For each measurement, DMSO/DMSO (*n* = 9; 18 cells), Thaps/DMSO (*n* = 9; 18 cells), DMSO/Bleb (*n* = 7; 14 cells), and Thaps/Bleb (*n* = 8; 16 cells). Scale bars, 25 μm.](875fig3){#F3}

Next we tested our hypothesis that Ca^2+^ mediates cell shape via NMII protein function, using two complementary rescue experiments that coupled modulation of intracellular Ca^2+^ levels with manipulation of NMII function. We used 2-APB or Thaps treatment to manipulate Ca^2+^ levels, as described in [Figure 2](#F2){ref-type="fig"}. NMII activity was manipulated using the pharmacological reagent blebbistatin (Bleb) or with *mypt1* gene knockdown to inhibit or activate NMII, respectively. Bleb is a well-established myosin II inhibitor ([@B20]), and *mypt1* encodes the regulatory subunit of myosin phosphatase and is required to inactivate pMRLC. Therefore *mypt1* knockdown leads to an increase in pMRLC, resulting in NMII overactivation ([@B17]; [@B14]).

In our first rescue experiments, we increased Ca^2+^ levels and rescued the cell-length phenotype with inhibition of NMII. We hypothesized that we could rescue Thaps-induced short cells by inhibiting NMII with Bleb ([Figure 3C](#F3){ref-type="fig"}). As predicted, we found that Thaps decreased cell length and Bleb increased cell length at the MHBC, and treatment of embryos with Thaps followed by Bleb rescued the abnormal-cell-length phenotypes specifically at the MHBC ([Figure 3, D--I](#F3){ref-type="fig"}). These data suggest that the Ca^2+^ signal affects cell length via modulation of NMII function. Quantification of tissue shape showed that the MHBC angle was abnormal, as expected with changes in MHBC cell length, but was also partially rescued with Thaps and Bleb treatment together. Bleb had a slight effect on MHB cell width, which is expected because Bleb inhibits both NMIIA and NMIIB, and we know that NMIIB is essential in mediating cell width (Supplemental Figure S3, C and D; [@B13]). Cell length outside of the MHBC was not significantly different from controls for any treatment ([Figure 3I](#F3){ref-type="fig"}), suggesting that MHBC cells are poised to respond to slight changes in intracellular Ca^2+^ levels.

In a complementary set of experiments, we overactivated NMII and rescued the cell-length phenotype by decreasing Ca^2+^ levels. We hypothesized that decreasing Ca^2+^ with 2-APB would specifically rescue short cells induced by NMII overactivation ([Figure 4A](#F4){ref-type="fig"}). The *mypt1* morphants revealed cells that were both shorter and wider than controls, as we previously reported ([Figure 4B](#F4){ref-type="fig"}; [@B14]; [@B13]). As predicted, cell length in *mypt1* morphants treated with 2-APB was rescued compared with *mypt1* morphant controls ([Figure 4, B--D](#F4){ref-type="fig"}). No other significant differences were observed ([Figure 4E](#F4){ref-type="fig"} and Supplemental Figure S3, E and F). We did not observe a rescue of the MHB tissue angle in these experiments, which is expected because we know that cell width also contributes to normal MHB tissue angle (Supplemental Figure S3, E and F).

![Calcium inhibition rescues NMII overactivation at the MHBC. (A) Hypothesized role of Ca^2+^ and NMII interactions. IF, inhibition of Ca^2+^ by 2-APB results in longer MHBC cells; AND, *mypt1* knockdown results in overactivation of MRLC, causing shorter and wider MHB cells; THEN, inhibition of Ca^2+^ in *mypt1*-knockdown embryos would rescue MHBC cell length. (B, C) Confocal images of 24-ss embryos coinjected with mGFP and *mypt1* MO and treated with (B) DMSO or (C) 2-APB. (B′, C′) Magnified images from B and C. Arrowheads indicate MHBC. (D, E) Cell length quantification at the MHBC and 40 μm outside the MHBC. For statistical analysis, the Mann--Whitney *U* test was done. \*\**p* \< 0.01, mean ± SEM. For each measurement, *mypt1* MO plus DMSO (*n* = 11; 22 cells) and *mypt1* MO plus 2-APB (*n =* 13; 26 cells). Scale bars, 25 μm.](875fig4){#F4}

Taking the results together, we showed in vivo that MHBC cell length is regulated by Ca^2+^ and NMII activity. These complementary rescue experiments further suggest an important correlation between regulation of cell length and NMII. In our previous work, we determined that NMIIA specifically regulates cell length at the MHBC ([@B13]). Here 2-APB rescues only the cell-length phenotype in *mypt1*-knockdown embryos, without the rescue of cell width. These results lead us to speculate that Ca^2+^ might signal through intermediate molecules specifically to NMIIA to differentially mediate cell length at the MHBC. Additional experiments are needed to specifically address this possibility.

Calmodulin and MLCK regulate cell shape at the MHB
--------------------------------------------------

Because Ca^2+^ is a ubiquitous ion and additional manipulations of Ca^2+^ levels are not region specific, the question remains as to how Ca^2+^ transients might lead to modulation of cell shape specifically at the MHBC. Ca^2+^ interacts with calcium-binding proteins to initiate downstream signaling cascades ([@B3]). Therefore one possible mechanism for a region-specific Ca^2+^ response to transient activity would be through tissue specific expression of a calcium-binding protein required to mediate cell shape changes. We hypothesized that the calcium-binding partner calmodulin, a highly conserved multifunctional Ca^2+^ sensor and signal transducer ([@B8]; [@B33]), might play a role in allowing MHBC cells to respond specifically to Ca^2+^.

Mammalian vertebrates express three *calmodulin* genes, whereas zebrafish have six *calmodulin* genes due to genome duplication that all encode the same calmodulin protein ([@B10]). In zebrafish, *calmodulin 3b* is ubiquitously expressed in the brain during development, whereas other *calmodulin* genes have region-specific expression ([@B30]; [@B31]), and the protein exhibits cell type--specific subcellular localization ([@B6]; [@B2]). Of particular interest is *calmodulin 1a* (*calm1a*), which was shown to have potential MHB-specific expression during development ([@B30]). Differential expression patterns of *calmodulin* have been observed in the eye and nervous system in other vertebrates ([@B9]; [@B32]; [@B19]); however, comparative expression patterns during neural tube formation and brain morphogenesis at the time points examined here have not been reported. We used in situ hybridization to confirm the MHB localized expression of *calm1a* during brain morphogenesis. We found that *calm1a* is expressed specifically at the MHB before and during the initiation of MHB morphogenesis, with other specific expression detectable in the trigeminal ganglia and otic vesicles ([Figure 5, A--C](#F5){ref-type="fig"}). Therefore, we hypothesized that the spatial localization of *calm1a* expression may provide an MHBC region-specific response to the Ca^2+^ transients. To test this, we knocked down *calm1a* using morpholino antisense oligonucleotides. We chose a knockdown method rather than a mutant approach because we hypothesize that the multiple *calmodulin* genes, all encoding the same protein, would lead to gene compensation, masking any specific role for *calm1a* in MHB tissue ([@B27]). The *calm1a* morpholino (MO) effectiveness and specificity were confirmed using RT-PCR, MHB tissue-specific Western analysis, and *calm1a* mRNA rescue (Supplemental Figure S4). The morpholino resulted in a deletion of exon 2 and an early stop codon as well as an approximate 50% reduction in calmodulin protein within the MHB region (Supplemental Figure S4, E--G). We found that *calm1a* knockdown resulted in longer MHBC cells but had no effect on cell length outside of the MHBC ([Figure 5, D--E](#F5){ref-type="fig"}′ and H--I). The MHBC cell length defect was rescued by *calm1a* mRNA expression (Supplemental Figure S4, H--L). The *calm1a* knockdown also had a dramatic effect on MHBC angle, as expected with the cell-length phenotype, but had no effect on MHB cell width (Supplemental Figure S3, G and H). These results indicate a requirement for *calm1a* in mediating cell length at the MHBC.

![*Calmodulin 1a* and MLCK mediate cell length at the MHBC. (A--C) *calm1a* gene expression by in situ hybridization. Arrowheads indicate MHBC, and arrows indicate trigeminal ganglia; asterisks indicate otic vesicle. F, forebrain; M, midbrain; H, hindbrain. (D--G′) Confocal images of embryos injected with mGFP and (D, D′) control MO, (E, E′) *calm1a* MO, (F, F′) MLCK mRNA, or (G, G′) *calm1a* MO and MLCK mRNA. (D′--G′) Magnification of D--G. Arrowheads indicate the MHBC. Asterisks in D--G indicate cell outlined in D′--G′. (H, I) Cell length quantification at the MHBC and 40 μm outside the MHBC. (J) Representative Western blots for pMRLC in MHB-specific tissue dissected after control MO or *calm1a* MO injection. (K) pMRLC Western quantification using α-tubulin as a control (*n* = 5). (L) Proposed signaling pathway for Ca^2+^ regulation of cell length at the MHBC. For statistical analysis, one-way ANOVA with Tukey's HSD post hoc test was done. \*\**p* \< 0.01 and \**p* \< 0.05 compared with control, mean ± SEM. Control MO (*n* = 17; 34 cells), *calm1a* MO (*n* = 19; 38 cells), MLCK mRNA (*n* = 13; 26 cells), and *calm1a* MO plus MLCK (*n* = 9; 18 cells). Scale bars, 25 μm.](875fig5){#F5}

One known downstream target of calmodulin is activation of MLCK ([@B16]), and activated MLCK is known to phosphorylate MRLC ([@B29]). Therefore we investigated the role for MLCK in regulation of cell shape at the MHBC. We overexpressed MLCK and found that cells at the MHBC and outside the MHBC were slightly shorter than control cells, indicating that overexpression of MLCK increased cell shortening throughout the region ([Figure 5, F, F', and H--I](#F5){ref-type="fig"}). MLCK expression had no effect on overall MHB angle because all cells had a cell length defect (Supplemental Figure S3, G and H). From these results, we hypothesized that *calm1a* and MLCK may function in the same pathway to mediate MHBC cell length. To test this, we coinjected embryos with *calm1a* MO and MLCK mRNA, which rescued the MHBC cell-length phenotype ([Figure 5, G--I](#F5){ref-type="fig"}), further suggesting that calmodulin works in conjunction with MLCK to regulate cell shape specifically at the MHBC. In addition, we hypothesized that *calm1a* knockdown would influence activation of NMII. Therefore we analyzed phosphorylated MRLC levels in MHB tissue microdissected from control and *calm1a* MO--injected embryos by Western blot, as in [Figure 2](#F2){ref-type="fig"}. Western analysis of MHB protein demonstrated that pMRLC levels decreased ∼50% with *calm1a* knockdown ([Figure 5, J and K](#F5){ref-type="fig"}), further indicating a requirement for *calm1a* at the MHB for NMII activity.

Together our results suggest a model in which Ca^2+^/calmodulin specifically activates MLCK at the MHBC to mediate cell length via activation of NMII ([Figure 5L](#F5){ref-type="fig"}). This is the first time a role for Ca^2+^-mediated regulation of cell length during brain morphogenesis has been demonstrated. We hypothesize that the specific expression of *calm1a* in this region is what allows the MHBC neuroepithelial cells to respond to Ca^2+^ transients that occur in the MHB region at the onset of morphogenesis.

MATERIALS AND METHODS
=====================

Zebrafish maintenance and husbandry
-----------------------------------

Zebrafish maintenance, husbandry procedures, and staging were followed as per [@B18] and [@B37]. Wild-type (AB and EK) zebrafish embryos were used for all experiments. Somites were counted to establish specific and consistent staging and eliminate concerns regarding potential developmental delay for all experiments. This study was approved by the University of Wisconsin--Milwaukee Institutional Animal Care and Use Committee.

Live imaging of calcium transients and analysis
-----------------------------------------------

For imaging of Ca^2+^ transients, wild-type single-cell embryos were injected with 100 ng of GCaMP6s-GFP mRNA encoding the Ca^2+^ indicator, a gift from Philipp Keller and Yinan Wan (Howard Hughes Medical Institute, Janelia Research Campus), and 100 ng mCherry mRNA. Live time-lapse imaging was conducted beginning at 18, 20, or 24 ss using a Nikon CS2 scanning confocal microscope. Time-lapse data sets were acquired as single slices or 5-μm *z*-stacks and taken ∼15--20 μm into the neural tube tissue from the dorsal surface at a frame rate of 10--30 s per image. Overall capture time was between 10 and 120 min, with the average total time being 35 min per embryo. Ca^2+^ transients observed were quantified spatially within the MHB region (∼10 μm on either side of the MHBC, ∼20 μm total) and the outside MHB region (∼30 μm on either side of the MHB region, ∼60 μm total). Therefore the MHB region accounted for 25% of the total area analyzed, and the outside MHB region accounted for 75% of the total area analyzed. To determine Ca^2+^ transient frequency, we normalized the number of Ca^2+^ transients observed during each time-lapse experiment to the number of transients per hour at an acquisition rate of one image per 10 s. Each region was normalized to represent an equal area of the neural tube tissue for comparison. To examine change in cell shape after Ca^2+^ transients, we measured the apical-basal length of single cells using the mCherry cell outline images. Single cells were measured during the Ca^2+^ transient, and the same cell was measured again immediately after the transient. Only cells in the MHBC region demonstrated decreases in cell length after Ca^2+^ transients. All confocal images were analyzed using the Nikon Imaging Systems (NIS) Elements software.

Drug treatments
---------------

Wild-type embryos were injected at the one-cell stage with 200 ng/μl membrane GFP (mGFP) mRNA (CAAX-eGFP). At 18 ss, embryos were dechorionated and treated for 10 min with 100 μM 2-APB (D9754-1G; Sigma-Aldrich), an inositol triphosphate receptor (IP~3~R) antagonist that blocks Ca^2+^ release from the endoplasmic reticulum, to decrease intracellular Ca^2+^ levels ([@B4]; [@B1]). Alternatively, embryos were treated for 15 min with 2 μM Thaps (T9033-1MG; Sigma-Aldrich), a sarcoplasmic and endoplasmic reticulum Ca^2+^ ATPase (SERCA) inhibitor that depletes Ca^2+^ stores, to increase intracellular Ca^2+^ levels ([@B21]; [@B38]). After the treatment times, embryos were washed and allowed to mature to 24 ss in 1% agarose--lined Petri dishes at 28°C and imaged using live confocal microscopy. DMSO control treatments were conducted using the same volume percentage as other treatment groups in each experiment. For Thaps/Bleb combined drug treatment rescue experiments, wild-type embryos were injected at the one-cell stage with mGFP mRNA. At 18 ss, embryos were separated into two treatment groups: DMSO or 2 μM Thaps. After treatment, embryos were washed and incubated at 28°C until 20--21 ss. At 20--21 ss, embryos from each treatment group were separated into two additional treatment groups: DMSO or 50 μM Bleb (B0560-1MG; Sigma-Aldrich). Finally, each group was incubated at 28°C until 24 ss and imaged using live confocal microscopy.

Live confocal imaging and cell shape analysis
---------------------------------------------

All mGFP live confocal imaging was conducted as previously described ([@B11]; [@B13]) using a Nikon CS2 scanning confocal microscope. Live confocal images presented in each figure are single slices taken from a *z*-series of images ∼15--20 μm into the tissue from the dorsal surface. All confocal images were processed using Nikon Imaging Systems (NIS) Elements software and Photoshop (Adobe). Cell shape analysis was performed as described in [@B13]. Briefly, cell length was determined using the NIS-Elements software measurement tool by measuring a single cell spanning the neuroepithelium from apical to basal in the region described, either directly at the MHBC or 40 μm posterior to the MHBC (outside the MHBC) on the hindbrain side.

Antisense MO oligonucleotide and mRNA injections
------------------------------------------------

All knockdown experiments were performed using splice site--blocking MO antisense oligonucleotides. MO details are as follows: *mypt1* MO (5′-ATTTTTTGTGACTTACTCAGCGATG-3′; [@B12], [@B13]), *calmodulin 1a* (ENSDART00000034580), and *calm1a* MO (5′-CCACAAACAGACTGCCTTACCTGCA-3′). Zebra­fish *p53* MO (5′-GCGCCATTGCTTTTGCAAGAATTG-3′) was used in conjunction with the *calm1a* MO at equal concentration. Standard control MO (5′-CCTCTTACCTCAGTTACAATTTATA-3′). All MOs are from Gene Tools. Morpholinos were injected into one-cell-stage embryos either alone or in conjunction with mGFP mRNA as indicated. MO concentrations were 5 ng *mypt1* MO, 2 ng *calm1a* MO, and 2 ng *p53* MO. Control MO concentration was equal to the highest concentration of any MO used in that experiment. For MLCK mRNA expression experiments, 50 ng of MLCK mRNA (zfMLCK fused to the globin 3′ untranslated region, kindly provided by Erez Raz, University of Munster, Munster, Germany), was injected with 200 ng/μl mGFP mRNA separately or combined with *calm1a* MO or control MO. All mRNA was in vitro transcribed for injections using the mMessage mMachine Transcription Kit (Ambion). Embryos were incubated at 28°C to 24 ss and imaged using live confocal microscopy.

In situ hybridization
---------------------

In situ hybridization was conducted according to standard procedures. For the EST/cDNA clone, *calm1a*, cb617, from ZFIN was used to produce the *calmodulin 1a* in situ probe. Bright-field imaging was conducted using an Olympus SZX12 stereomicroscope with an Olympus DP72 camera.

Western blot analysis with MHB-specific tissue
----------------------------------------------

Embryos were dechorionated and treated as described with either DMSO or Thaps at 18 ss. Alternatively, embryos were injected with *calm1a* MO or control MO. MHB tissue was dissected from 18 to 24 ss for protein isolation and analysis (see Supplemental Figure S4 for details). Primary antibodies were pMLC2 (pMRLC; 3671; Cell Signaling Technology) at 1:500 ([@B14]) and α-tubulin (T6199; Sigma-Aldrich) at 1:1000. Secondary antibodies were anti-mouse horseradish peroxidase (HRP; 7076S; Cell Signaling Technology) and anti-rabbit HRP (7074S; Cell Signaling Technology) at 1:2000. Blots were imaged on a UVP Biospectrum Imaging System.

Statistical analyses
--------------------

Statistical analysis between two groups was carried out using the Mann--Whitney *U* test; *p* values denoting significance are reported in each figure legend. Statistical analysis for comparisons between more than two treatment groups was carried out by one-way analysis of variance (ANOVA). For ANOVA *p* \< 0.05, Tukey's honest significant difference (HSD) post hoc tests were performed to determine significance between control treatment and experimental treatment groups. The *p* values for post hoc comparisons are presented in each figure legend. All ANOVA and Tukey's HSD post hoc analyses were carried out using R-3.1.2. At least three independent experiments were conducted for all data presented; *n* indicates the total number of embryos analyzed, and numbers of single cells analyzed are indicated where necessary.
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:   midbrain--hindbrain boundary
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[^1]: The authors declare no competing interests.

[^2]: ^†^These authors contributed equally to this work.

[^3]: S.U.S. performed experiments and assisted in conceptualizing ideas. M.R.V. performed experiments, conceptualized ideas, and completed all statistical analysis. R.J.G., L.H., and C.K. performed experiments. J.G. conceptualized ideas, performed experiments, and drafted the manuscript. All authors contributed to drafting and revising the manuscript.

[^4]: Present addresses: ^‡^Aptinyx, 1801 Maple Ave., Suite 4300, Evanston, IL 60201;

[^5]: ^§^Blood Research Institute, 8733 Watertown Plank Rd., Milwaukee, WI 53226.
